(BCY) Barclays - Ratings and Ratios
Banking, CreditCards, Investment, WealthManagement, LendingProducts
BCY EPS (Earnings per Share)
BCY Revenue
Description: BCY Barclays
Barclays PLC is a multinational financial services corporation with a presence in various regions, including the UK, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through multiple segments, offering a range of financial services such as retail banking, credit cards, wholesale banking, investment banking, wealth management, and investment management.
With a history dating back to 1690, Barclays PLC has established itself as a major player in the global banking industry. Its diversified business model and geographic presence provide a solid foundation for generating revenue. Key Performance Indicators (KPIs) such as Return on Equity (RoE) of 9.13% and a Forward Price-to-Earnings ratio of 7.97 suggest a relatively stable and profitable business.
From a valuation perspective, Barclays PLC has a Market Capitalization of approximately 54.5 billion EUR, indicating a significant market presence. The companys diversified banks sub-industry classification and common stock type make it an attractive investment opportunity for those seeking exposure to the financial sector. Additional KPIs, such as the companys dividend yield and payout ratio, could provide further insights into its investment potential.
To gain a deeper understanding of Barclays PLCs financial health, it is essential to analyze its revenue breakdown by segment, as well as its asset quality and capital adequacy ratios. Key metrics such as the Net Interest Margin (NIM), Cost-to-Income ratio, and Leverage ratio can help investors assess the companys profitability, efficiency, and risk profile.
BCY Stock Overview
Market Cap in USD | 73,191m |
Sub-Industry | Diversified Banks |
IPO / Inception |
BCY Stock Ratings
Growth Rating | 91.0% |
Fundamental | 55.1% |
Dividend Rating | 74.3% |
Return 12m vs S&P 500 | 41.3% |
Analyst Rating | - |
BCY Dividends
Dividend Yield 12m | 2.87% |
Yield on Cost 5y | 13.35% |
Annual Growth 5y | 9.63% |
Payout Consistency | 88.5% |
Payout Ratio | 13.9% |
BCY Growth Ratios
Growth Correlation 3m | 87.4% |
Growth Correlation 12m | 93.6% |
Growth Correlation 5y | 64.9% |
CAGR 5y | 43.95% |
CAGR/Max DD 3y | 1.61 |
CAGR/Mean DD 3y | 11.32 |
Sharpe Ratio 12m | 2.44 |
Alpha | 0.00 |
Beta | 0.751 |
Volatility | 32.93% |
Current Volume | 116.7k |
Average Volume 20d | 834.4k |
Stop Loss | 4.2 (-4.3%) |
Signal | 0.38 |
Piotroski VR‑10 (Strict, 0-10) 4.0
Net Income (7.02b TTM) > 0 and > 6% of Revenue (6% = 2.35b TTM) |
FCFTA 0.00 (>2.0%) and ΔFCFTA 0.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -1044 % (prev 988.2%; Δ -2032 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.00 (>3.0%) and CFO 7.11b > Net Income 7.02b (YES >=105%, WARN >=100%) |
Net Debt (-108.28b) to EBITDA (7.94b) ratio: -13.64 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.36 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (15.27b) change vs 12m ago -3.66% (target <= -2.0% for YES) |
Gross Margin 35.05% (prev 98.45%; Δ -63.40pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 2.46% (prev 1.57%; Δ 0.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 0.07 (EBITDA TTM 7.94b / Interest Expense TTM 25.39b) >= 6 (WARN >= 3) |
Altman Z'' -1.51
(A) -0.26 = (Total Current Assets 225.72b - Total Current Liabilities 633.84b) / Total Assets 1598.70b |
(B) 0.04 = Retained Earnings (Balance) 57.75b / Total Assets 1598.70b |
(C) 0.00 = EBIT TTM 1.83b / Avg Total Assets 1587.67b |
(D) 0.04 = Book Value of Equity 61.95b / Total Liabilities 1522.35b |
Total Rating: -1.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.11
1. Piotroski 4.0pt = -1.0 |
2. FCF Yield 0.41% = 0.21 |
3. FCF Margin 14.17% = 3.54 |
4. Debt/Equity 20.06 = -2.50 |
5. Debt/Ebitda 191.8 = -2.50 |
6. ROIC - WACC (= -0.85)% = -1.06 |
7. RoE 9.56% = 0.80 |
8. Rev. Trend 63.28% = 4.75 |
9. EPS Trend 57.62% = 2.88 |
What is the price of BCY shares?
Over the past week, the price has changed by +0.80%, over one month by +1.39%, over three months by +16.36% and over the past year by +67.50%.
Is Barclays a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCY is around 4.98 EUR . This means that BCY is currently undervalued and has a potential upside of +13.44% (Margin of Safety).
Is BCY a buy, sell or hold?
What are the forecasts/targets for the BCY price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 5.3 | 19.6% |
BCY Fundamental Data Overview
Market Cap GBP = 53.73b (61.94b EUR * 0.8675 EUR.GBP)
CCE Cash And Equivalents = 225.72b GBP (Cash And Short Term Investments, last quarter)
P/E Trailing = 9.4043
P/E Forward = 7.4516
P/S = 2.4145
P/B = 0.7072
P/EG = 1.3075
Beta = 1.023
Revenue TTM = 39.09b GBP
EBIT TTM = 1.83b GBP
EBITDA TTM = 7.94b GBP
Long Term Debt = 888.50b GBP (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 633.84b GBP (from totalCurrentLiabilities, last quarter)
Debt = 1522.35b GBP (Calculated: Short Term 633.84b + Long Term 888.50b)
Net Debt = -108.28b GBP (from netDebt column, last quarter)
Enterprise Value = 1350.36b GBP (53.73b + Debt 1522.35b - CCE 225.72b)
Interest Coverage Ratio = 0.07 (Ebit TTM 1.83b / Interest Expense TTM 25.39b)
FCF Yield = 0.41% (FCF TTM 5.54b / Enterprise Value 1350.36b)
FCF Margin = 14.17% (FCF TTM 5.54b / Revenue TTM 39.09b)
Net Margin = 17.95% (Net Income TTM 7.02b / Revenue TTM 39.09b)
Gross Margin = 35.05% ((Revenue TTM 39.09b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Tobins Q-Ratio = 21.80 (Enterprise Value 1350.36b / Book Value Of Equity 61.95b)
Interest Expense / Debt = 1.67% (Interest Expense 25.39b / Debt 1522.35b)
Taxrate = 21.61% (1.75b / 8.11b)
NOPAT = 1.44b (EBIT 1.83b * (1 - 21.61%))
Current Ratio = 0.36 (Total Current Assets 225.72b / Total Current Liabilities 633.84b)
Debt / Equity = 20.06 (Debt 1522.35b / last Quarter total Stockholder Equity 75.91b)
Debt / EBITDA = 191.8 (Net Debt -108.28b / EBITDA 7.94b)
Debt / FCF = 274.8 (Debt 1522.35b / FCF TTM 5.54b)
Total Stockholder Equity = 73.39b (last 4 quarters mean)
RoA = 0.44% (Net Income 7.02b, Total Assets 1598.70b )
RoE = 9.56% (Net Income TTM 7.02b / Total Stockholder Equity 73.39b)
RoCE = 0.19% (Ebit 1.83b / (Equity 73.39b + L.T.Debt 888.50b))
RoIC = 0.71% (NOPAT 1.44b / Invested Capital 201.71b)
WACC = 1.56% (E(53.73b)/V(1576.08b) * Re(8.78%)) + (D(1522.35b)/V(1576.08b) * Rd(1.67%) * (1-Tc(0.22)))
Shares Correlation 3-Years: -58.47 | Cagr: -0.80%
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 67.19% ; FCFE base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 2.07 (DCF Value 28.96b / Shares Outstanding 14.01b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 57.62 | EPS CAGR: 148.7% | SUE: N/A | # QB: 0
Revenue Correlation: 63.28 | Revenue CAGR: 50.84% | SUE: N/A | # QB: None